Pharmacology

Relevant Content

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities

Women's Health ... Guideline Publication Schedule ... ASCVD Risk Calculator HCM-AF Risk Calculator Combined Adult/Pediatric Hypertrophic Cardiomyopathy Calculator for Risk of Sudden ...

Survival With β‐Adrenergic Suppression After Lung Transplantation

Journal of the American Heart Association, Volume 15, Issue 12, June 16, 2...

Direct Oral Anticoagulant Monotherapy Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: A Meta-Analysis of Randomized Trials

Circulation: Cardiovascular Interventions, Ahead of Print.

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients

Circulation, Volume 153, Issue 25, Page 1999-2010, June 23, 2026.
BAC...

AH001: A New Drug Targeting RhoA in Heart Failure

Circulation Research, Volume 138, Issue 10, Page e328631, May 8, 2026. Response by Szczeklik et al to Letter Regarding Article, “Ivabradine in Patients Undergoing Noncardiac Surgery: A Randomized Controlled Trial”

Circulation, Volume 153, Issue 18, Page e1283-e1284, May 5, 2026.

Letter by Lu et al Regarding Article, “Ivabradine in Patients Undergoing Noncardiac Surgery: A Randomized Controlled Trial”

Circulation, Volume 153, Issue 18, Page e1279-e1280, May 5, 2026.

Precision Antiplatelet Therapy: The Promise and Complexity of Pharmacogenomic Antiplatelet Therapy

Circulation: Cardiovascular Interventions, Ahead of Print.

Dimethyl Fumarate Reverses β‐Adrenoceptor–Mediated Myocardial Fibrosis in Mice by Inhibiting Yes‐Associated Protein–Regulated Expression of Intermediate‐Conductance Ca2+‐Activated K+ Channel in Fibroblasts

Journal of the American Heart Association, Ahead of Print.
Background...